When we established the Champion level of the AAFP Foundation Partners Program, it came as no surprise that Novo Nordisk, Inc., was the first company to step up with the $75,000 contribution. Over the years, Novo Nordisk has repeatedly demonstrated its commitment to our philanthropic work, and its understanding of the invaluable role family doctors play in the healthcare system.

Today, as an ongoing Champion, Novo Nordisk shares a number of priorities with the AAFP Foundation. Novo Nordisk values partnerships and is an ally to the AAFP in efforts to improve the management and treatment of diabetes and other chronic diseases by family physicians, with particular emphasis on identifying ways to mitigate worsening of conditions and co-morbidities. Family physicians are often the first line of defense against diabetes, obesity, and many endocrine disorders – not all patients have access to an endocrinologist.

Novo Nordisk(www.novonordisk-us.com) is a global health care company that has been committed to helping people with diabetes and other chronic diseases such as obesity, and rare blood and endocrine disorders lead longer, healthier lives for nearly 100 years. In addition to making innovative medicines to help people manage their disease, Novo Nordisk offers a range of access and support programs including numerous affordability offerings to help make medicines, including insulin, more affordable for people who need them. The company strives to ultimately defeat diabetes through better prevention, detection and management, and empower people with chronic disease to live life with as few limitations as possible.

The AAFP Foundation thanks Novo Nordisk for its ongoing, generous support, and invites others to learn more about the AAFP Foundation Partner Program (www.aafpfoundation.org).